Koizumi, Shigeru
Inozume, Takashi
Nakamura, Yasuhiro
Funding for this research was provided by:
Saitama Medical University
Article History
Received: 4 September 2025
Accepted: 29 September 2025
First Online: 27 October 2025
Declarations
:
: Dr. Yasuhiro Nakamura has received research funding and has served as a consultant and/or received honoraria from Alexion Pharma, Bristol-Myers Squibb, Dai-ichi Sankyo, HUYA Bioscience International, Kyowa Kirin, LEO Pharma, Maruho, MSD, Novartis Ono Pharma, Pierre Fabre, Sanofi, Sun Pharma, and Tanabe-Mitsubishi Pharma.